$NPCE NeuroPace Inc Insider Trading
Get free email notifications about insider trading in NeuroPace Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NeuroPace Inc. Insider overview, share value development, latest insider transactions and email notifications about new events in NeuroPace Inc for free.
CIK Number: 0001528287
IRS Number: 223550230
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: NPCE
Company Address: 455 N. BERNARDO AVENUE MOUNTAIN VIEW 94043
Phone number: 6502372700
NeuroPace Inc Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 26 2021 | NPCE | NeuroPace Inc | Fischer Frank M | Director | Option Exercise | C | 0.00 | 450,880 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Fischer Frank M | Director | Option Exercise | C | 0.00 | 21,486 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Fischer Frank M | Director | Buy | C | 0.00 | 472,366 | 0 | 565,657 | 93.3 K to 565.7 K (+506.34 %) |
Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 3,605,386 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 171,895 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 3,777,281 | 0 | 4,012,281 | 235 K to 4 M (+1,607.35 %) |
Apr 26 2021 | NPCE | NeuroPace Inc | Norton Evan | Director | Option Exercise | C | 0.00 | 3,454,422 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Norton Evan | Director | Buy | C | 0.00 | 3,454,422 | 0 | 4,042,657 | 588.2 K to 4 M (+587.25 %) |
Apr 26 2021 | NPCE | NeuroPace Inc | Accelmed Partners II L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,454,422 | 0 | 3,454,422 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Accelmed Partners II L.P. | 10% Owner | Buy | C | 0.00 | 3,454,422 | 0 | 4,042,657 | 588.2 K to 4 M (+587.25 %) |
Apr 26 2021 | NPCE | NeuroPace Inc | Garfield Greg Shaw | Director | Option Exercise | C | 0.00 | 5,271,902 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Garfield Greg Shaw | Director | Option Exercise | C | 0.00 | 323,591 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Garfield Greg Shaw | Director | Option Exercise | C | 0.00 | 18,032 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Garfield Greg Shaw | Director | Option Exercise | C | 0.00 | 859 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Garfield Greg Shaw | Director | Buy | C | 0.00 | 5,595,493 | 0 | 5,614,384 | 18.9 K to 5.6 M (+29,619.89 %) |